ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: QUIGLEY, Anna, Maria, Matilda, DOYLE, Anthony, Gerard, POULTON, Lynn, POLLARD, Matthew, BRACKEN, Anna, Mikaela, CLARKE, Adam, LIDDAMENT, Mark, Terence, COOKSEY, Bridget, A, SZABAT, Marta, ROZENFELD, Julia
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator QUIGLEY, Anna, Maria, Matilda
DOYLE, Anthony, Gerard
POULTON, Lynn
POLLARD, Matthew
BRACKEN, Anna, Mikaela
CLARKE, Adam
LIDDAMENT, Mark, Terence
COOKSEY, Bridget, A
SZABAT, Marta
ROZENFELD, Julia
description The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4200018B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4200018B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4200018B13</originalsourceid><addsrcrecordid>eNrjZDBw9Avx1A1wDNI1UgAxnfxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBiZGBgYGjhZGhMhBIAqu0lUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><source>esp@cenet</source><creator>QUIGLEY, Anna, Maria, Matilda ; DOYLE, Anthony, Gerard ; POULTON, Lynn ; POLLARD, Matthew ; BRACKEN, Anna, Mikaela ; CLARKE, Adam ; LIDDAMENT, Mark, Terence ; COOKSEY, Bridget, A ; SZABAT, Marta ; ROZENFELD, Julia</creator><creatorcontrib>QUIGLEY, Anna, Maria, Matilda ; DOYLE, Anthony, Gerard ; POULTON, Lynn ; POLLARD, Matthew ; BRACKEN, Anna, Mikaela ; CLARKE, Adam ; LIDDAMENT, Mark, Terence ; COOKSEY, Bridget, A ; SZABAT, Marta ; ROZENFELD, Julia</creatorcontrib><description>The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2025</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20250101&amp;DB=EPODOC&amp;CC=EP&amp;NR=4200018B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20250101&amp;DB=EPODOC&amp;CC=EP&amp;NR=4200018B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QUIGLEY, Anna, Maria, Matilda</creatorcontrib><creatorcontrib>DOYLE, Anthony, Gerard</creatorcontrib><creatorcontrib>POULTON, Lynn</creatorcontrib><creatorcontrib>POLLARD, Matthew</creatorcontrib><creatorcontrib>BRACKEN, Anna, Mikaela</creatorcontrib><creatorcontrib>CLARKE, Adam</creatorcontrib><creatorcontrib>LIDDAMENT, Mark, Terence</creatorcontrib><creatorcontrib>COOKSEY, Bridget, A</creatorcontrib><creatorcontrib>SZABAT, Marta</creatorcontrib><creatorcontrib>ROZENFELD, Julia</creatorcontrib><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><description>The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2025</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9Avx1A1wDNI1UgAxnfxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBiZGBgYGjhZGhMhBIAqu0lUg</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>QUIGLEY, Anna, Maria, Matilda</creator><creator>DOYLE, Anthony, Gerard</creator><creator>POULTON, Lynn</creator><creator>POLLARD, Matthew</creator><creator>BRACKEN, Anna, Mikaela</creator><creator>CLARKE, Adam</creator><creator>LIDDAMENT, Mark, Terence</creator><creator>COOKSEY, Bridget, A</creator><creator>SZABAT, Marta</creator><creator>ROZENFELD, Julia</creator><scope>EVB</scope></search><sort><creationdate>20250101</creationdate><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><author>QUIGLEY, Anna, Maria, Matilda ; DOYLE, Anthony, Gerard ; POULTON, Lynn ; POLLARD, Matthew ; BRACKEN, Anna, Mikaela ; CLARKE, Adam ; LIDDAMENT, Mark, Terence ; COOKSEY, Bridget, A ; SZABAT, Marta ; ROZENFELD, Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4200018B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2025</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>QUIGLEY, Anna, Maria, Matilda</creatorcontrib><creatorcontrib>DOYLE, Anthony, Gerard</creatorcontrib><creatorcontrib>POULTON, Lynn</creatorcontrib><creatorcontrib>POLLARD, Matthew</creatorcontrib><creatorcontrib>BRACKEN, Anna, Mikaela</creatorcontrib><creatorcontrib>CLARKE, Adam</creatorcontrib><creatorcontrib>LIDDAMENT, Mark, Terence</creatorcontrib><creatorcontrib>COOKSEY, Bridget, A</creatorcontrib><creatorcontrib>SZABAT, Marta</creatorcontrib><creatorcontrib>ROZENFELD, Julia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QUIGLEY, Anna, Maria, Matilda</au><au>DOYLE, Anthony, Gerard</au><au>POULTON, Lynn</au><au>POLLARD, Matthew</au><au>BRACKEN, Anna, Mikaela</au><au>CLARKE, Adam</au><au>LIDDAMENT, Mark, Terence</au><au>COOKSEY, Bridget, A</au><au>SZABAT, Marta</au><au>ROZENFELD, Julia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><date>2025-01-01</date><risdate>2025</risdate><abstract>The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4200018B1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T23%3A11%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QUIGLEY,%20Anna,%20Maria,%20Matilda&rft.date=2025-01-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4200018B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true